Two separate studies appearing in JAMA cast doubt on the practical value of genetic testing to improve cardiovascular risk assessment. In the first study, Nina Paynter and colleagues, led by Paul Ridker, calculated genetic risk scores based on 101 SNPs (single nucleotide polymorphisms) from 19,313 women enrolled in the Women's Genome Health Study. They found that [...]
--
This article was sent using my Viigo.
For a free download, go to http://getviigo.com
Sent from my Verizon Wireless BlackBerry
No comments:
Post a Comment